| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | Nov 10, 2025 | Mural Oncology plc | Chief Medical Officer | Sell | 36.3 | -5,036 | -5.61% | ✓ | $10.5K |
| Feb 24, 2025 | Feb 25, 2025 | Mural Oncology plc | Chief Medical Officer | Sell | 20.0 | -13,186 | -19.41% | ✓ | $51.3K |
| Nov 7, 2024 | Nov 8, 2024 | Mural Oncology plc | Chief Medical Officer | Sell | 36.3 | -5,069 | -6.94% | ✓ | $16.9K |
| Feb 15, 2023 | Feb 17, 2023 | EXELIXIS, INC. | EVP, Prod Dev & Med Aff &CMO | Sell | 20.0 | -17,299 | -7.14% | ✗ | $312.8K |
| Jan 4, 2022 | Jan 6, 2022 | EXELIXIS, INC. | EVP, Prod Dev & Med Aff &CMO | Sell | 95.0 | +242,387 | 100.00% | ✗ | $146K |